PRESS RELEASE published on 03/16/2026 at 08:00, 16 days 18 hours ago Capital B confirme l'acquisition de 8 BTC pour 0,5 M EUR , la détention d'un total de 2 844 BTC, et un 'BTC Yield' de 0,29% depuis le début de l'année Capital B réalise une augmentation de capital avec TOBAM pour 0,6 M€ et acquiert 8 BTC pour 0,5 M€. Détient 2 844 BTC valorisés à 264,4M€. Stratégie Bitcoin Treasury Company Augmentation De Capital Bitcoin Treasury Company Acquisition BTC TOBAM Capital B
PRESS RELEASE published on 03/16/2026 at 08:00, 16 days 18 hours ago Capital B confirms the acquisition of 8 BTC for EUR 0.5 million, the holding of a total of 2,844 BTC, and a BTC Yield of 0,29% YTD Capital B, a Bitcoin Treasury Company, completes capital increase at €0.71 per share, acquiring 8 BTC worth €0.5M. Achieved BTC Yield, Gain & € Gain; holds 2,844 BTC worth €264.4M. Details & strategy on website Capital Increase Bitcoin Treasury Company BTC Yield Capital B BTC Gain
PRESS RELEASE published on 03/16/2026 at 07:30, 16 days 18 hours ago Mutares posts another record year: According to preliminary, unaudited figures, Mutares increases Group revenues and Holding’s net income in the fiscal year 2025 – medium-term targets raised to 25%... Mutares SE & Co. KGaA reports record year in 2025, with increased Group revenues and Holding's net income. Medium-term targets set for 25% annual growth in Holding's profit and Group revenues Net Income Record Year Mutares Medium-term Targets Group Revenues
PRESS RELEASE published on 03/16/2026 at 07:30, 16 days 18 hours ago Le Groupe CAFOM est retenu pour assurer la relance des marques Brandt, De Dietrich, Sauter et Vedette Le Groupe CAFOM relance les marques Brandt, De Dietrich, Sauter et Vedette suite à leur liquidation judiciaire. Partenariats avec ARPA, EverEver et SOS Accessoire pour réindustrialisation en France Liquidation Judiciaire Groupe CAFOM Réindustrialisation Reprise Marques Partenariats ARPA EverEver SOS Accessoire
PRESS RELEASE published on 03/16/2026 at 07:30, 16 days 18 hours ago OSE Immunotherapeutics Announces its 2026 Financial Calendar OSE Immunotherapeutics announces its 2026 financial calendar, including key dates for financial updates and statements, and annual general meeting Annual General Meeting Financial Updates Biotech Company OSE Immunotherapeutics 2026 Financial Calendar
PRESS RELEASE published on 03/16/2026 at 07:30, 16 days 18 hours ago OSE Immunotherapeutics annonce son calendrier financier pour 2026 OSE Immunotherapeutics annonce son calendrier financier 2026 incluant résultats, trésorerie et AG des actionnaires. Société de biotechnologie en IO et I&I. Informations prospectives Biotechnologie Calendrier Financier Déclarations Prospectives Immuno-oncologie OSE Immunotherapeutics
PRESS RELEASE published on 03/16/2026 at 07:24, 16 days 18 hours ago EQS-Adhoc: UBS AG: UBS publishes agenda for its Annual General Meeting on 15 April 2026 UBS AG announces agenda for 2026 Annual General Meeting on 15 April 2026, including dividend proposal and board member elections Annual General Meeting Dividend Proposal Board Elections Agenda UBS AG
PRESS RELEASE published on 03/16/2026 at 07:05, 16 days 19 hours ago Hypoport delivers solid gross margin growth and disproportionate EBIT increase in 2025 Hypoport SE reports strong 2025 results with 10% gross margin growth and 85% EBIT increase, targeting further profitability improvements by 2030 Financial Performance Profitability Hypoport SE Growth 2025 Results
PRESS RELEASE published on 03/16/2026 at 07:02, 16 days 19 hours ago Changes to the Board of Directors of Julius Baer Group Julius Baer Group announces changes to the Board of Directors ahead of the upcoming Annual General Meeting, including the retirement of Olga Zoutendijk and the nomination of Colin Bell Board Of Directors Annual General Meeting Julius Baer Group Olga Zoutendijk Colin Bell
PRESS RELEASE published on 03/16/2026 at 07:00, 16 days 19 hours ago BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start BioVersys receives US FDA green light for BV100 HABP/VABP Phase 3 pivotal trial start to address CRABC infections in hospital-acquired bacterial pneumonia. A significant step in developing novel antibacterial products for MDR bacteria Phase 3 BV100 BioVersys US FDA CRABC
Published on 04/02/2026 at 00:55, 1 hour 21 minutes ago Silver Spruce Resources Inc. Announces Close of $739,250 First Tranche of Non-Brokered Private Placement and Extension
Published on 04/02/2026 at 00:00, 2 hours 16 minutes ago Redwood AI Launches Collaborative Research Project with UBC's Brent Page Lab Focused on Alzheimer's Drug Discovery
Published on 04/01/2026 at 23:15, 3 hours 1 minute ago Golden Minerals Reports Full Year 2025 Results
Published on 04/01/2026 at 18:15, 8 hours 1 minute ago Loop Industries to Present at Gabelli Waste & Sustainability Symposium
Published on 04/02/2026 at 00:52, 1 hour 24 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3H
Published on 04/01/2026 at 22:23, 3 hours 53 minutes ago EQS-Adhoc: Deutsche Börse AG: US court grants decision to plaintiffs’ group seeking turnover of assets attributed to Bank Markazi and held by Clearstream
Published on 04/01/2026 at 22:05, 4 hours 11 minutes ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers
Published on 04/01/2026 at 22:05, 4 hours 11 minutes ago Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
Published on 04/01/2026 at 19:16, 6 hours 59 minutes ago Mars 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 04/01/2026 at 18:15, 8 hours 1 minute ago Accor signs a memorandum of understanding on the sale of its stake in Essendi
Published on 04/01/2026 at 18:15, 8 hours 1 minute ago Accor a signé un protocole d’accord pour la cession de sa participation dans Essendi
Published on 04/01/2026 at 18:02, 8 hours 14 minutes ago CP MOULINVEST : TRANSFERT DU CONTRAT DE LIQUIDITE AUPRES DE TPICAP
Published on 04/01/2026 at 18:00, 8 hours 16 minutes ago Closing of acquisition of Chaplin's World operating company